3 0
So I bought ADRO yesterday at $33.66 and in a day's time it's down about 5%. I saw their partnership with Novartis recently and also saw many analysts ratings around $40, one even at $70. I understand to take this with a grain of salt, but just curious if anyone else is in this, and what they think of the company and potential price action?

I see the recent decline as mostly profit sharing from people who bought in two weeks ago and rode the spike from high 20s into the mid 30s, but the company as a whole being healthy and with a strong pipeline for the future.



Junior member
13 0
I think, investing in biotech stocks is a bit risky, maybe because of the uncertainty in it's success rate. So, I would suggest to do the thorough analysis before you go for such investments.
AdBlock Detected

We get it, advertisements are annoying!

But it's thanks to our sponsors that access to Trade2Win remains free for all. By viewing our ads you help us pay our bills, so please support the site and disable your AdBlocker.

I've Disabled AdBlock